Saurabh Agarwal

11PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfant and child healthMedical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 25, 2026
CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target.

|Oct 29, 2025
Direct Targeting of CXCR2 Receptor Inhibits Neuroblastoma Growth: An In Vitro Assessment.

Rameswari Chilamakuri, Deepika Godugu, Saurabh Agarwal

|Oct 16, 2025
Striking at Survivin: YM-155 Inhibits High-Risk Neuroblastoma Growth and Enhances Chemosensitivity.

Danielle C Rouse, Rameswari Chilamakuri, Saurabh Agarwal

|Oct 26, 2024
Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth.

Rameswari Chilamakuri, Saurabh Agarwal

|Jul 29, 2023
Pediatric Cancers: Insights and Novel Therapeutic Approaches.

Saurabh Agarwal

|Nov 26, 2022
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo.

Yang Yu, Yanling Zhao, Jongmin Choi

Pageof 2

Frequent Collaborators

7 joint publications

Rameswari Chilamakuri

2 joint publications

Yanling Zhao

2 joint publications

Jongmin Choi

2 joint publications

Feng Cheng